The effect of medication use on urinary incontinence in community-dwelling elderly women

Journal of the American Geriatrics Society

Volumn 58, Issue 9, 2010, Pages 1715-1720

  Ruby, Christine M ^a   Hanlon, Joseph T ^a,b   Boudreau, Robert M ^a   Newman, Anne B ^a   Simonsick, Eleanor M ^c   Shorr, Ronald I ^d   Bauer, Douglas C ^e   Resnick, Neil M ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

aged; medications; pharmacoepidemiology; urinary incontinence

Indexed keywords

ALFUZOSIN; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; DOXAZOSIN; ESTROGEN; LOOP DIURETIC AGENT; NEUROLEPTIC AGENT; OPIATE; POTASSIUM SPARING DIURETIC AGENT; PRAZOSIN; TAMSULOSIN; TERAZOSIN; THIAZIDE DIURETIC AGENT; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS;

AGED; ARTICLE; DISEASE COURSE; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; RACE DIFFERENCE; RISK FACTOR; SELF REPORT; SEMI STRUCTURED INTERVIEW; URINE INCONTINENCE; CARDIOVASCULAR DISEASES; CENTRAL NERVOUS SYSTEM DISEASES; CHEMICALLY INDUCED; COMPARATIVE STUDY; DRUG EFFECTS; FOLLOW UP; INCIDENCE; PATHOPHYSIOLOGY; PROGNOSIS; QUESTIONNAIRE; RETROSPECTIVE STUDY; TIME; UNITED STATES; URINARY INCONTINENCE; URODYNAMICS;

AGED; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CENTRAL NERVOUS SYSTEM AGENTS; CENTRAL NERVOUS SYSTEM DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; PROGNOSIS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; UNITED STATES; URINARY INCONTINENCE; URODYNAMICS;

EID: 77956304712     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2010.03006.x     Document Type: Article

References (27)

1. Ouslander JG. Management of overactive bladder. N Engl J Med 2004 350 : 786 799.
2. Chang C-H, Gonzalez CM, Lau DT et al. Urinary incontinence and self-reported health among the U.S. Medicare managed care beneficiaries. J Aging Health 2008 20 : 405 419.
3. DuBeau CE. Therapeutic/pharmacologic approaches to urinary incontinence in older adults. Clin Pharmacol Ther 2009 85 : 98 102.
4. Tsakiris P, Oekle M, Michel MC. Drug induced urinary incontinence. Drugs Aging 2008 25 : 541 549.
5. Grady D, Brown JS, Vittinghoff E et al. Postmenopausal hormones and incontinence: The Heart and Estrogen/Progestin Replacement Study. Obstet Gynecol 2001 97 : 116 120.
6. Hendrix SL, Cochrane BB, Nygaard IE et al. Effects of estrogen with and without progestin on urinary incontinence. JAMA 2005 293 : 935 948.
7. Grodstein F, Lifford K, Resnick NM et al. Postmenopausal hormone therapy and the risk of developing urinary incontinence. Obstet Gynecol 2004 103 : 254 260.
8. Landi F, Cesari M, Russo A et al. Benzodiazepines and the risk of urinary incontinence in frail older persons living in the community. Clin Pharmacol Ther 2002 72 : 729 734.
9. Movig KL, Leufkens HG, Belitser SV et al. Selective serotonin reuptake inhibitor-induced urinary incontinence. Pharmacoepidemiol Drug Safe 2002 11 : 271 279.
10. Finkelstein M. Medical conditions, medications, and urinary incontinence: Analysis of a population-based survey. Can Fam Physician 2002 48 : 96 101.
11. Ruby CM, Hanlon JT, Fillenbaum GG et al. Medication use and control of urination among community dwelling elderly. J Aging Health 2005 17 : 661 674.
12. Marshall H, Beevers D. Alpha-adrenoceptor blocking drugs and female urinary incontinence: Prevalence and reversibility. Br J Clin Pharmacol 1996 42 : 507 509.
13. Newman AB, Haggerty CL, Kritchevsky SB et al. Walking performance and cardiovascular response: Associations with age and morbidity. The Health, Aging and Body Composition Study. J Gerontol A Biol Sci Med Sci 2003 58A : M715 M720.
14. Pahor M, Chrischilles EA, Guralnik JM et al. Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol 1994 10 : 405 411.
15. Jackson RA, Vittinghoff E, Kanaya AM et al. Urinary incontinence in elderly women: Findings from the Health, Aging and Body Composition Study. Obstet Gynecol 2004 104 : 301 307.
16. Hanlon JT, Boudreau RM, Roumani YF et al. The impact of central nervous system medication dosage on recurrent falls in community elders: The Health, Aging and Body Composition Study. J Gerontol A Biol Sci Med Sci 2009 64A (No.4) : 492 498.
17. Fick DM, Cooper JW, Wade WE et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: Results of a US consensus panel of experts. Arch Intern Med 2003 163 : 2716 2724.
18. Radloff LS. The CES-D scale: A self-report depression scale for research use in the general population. Appl Psych Measur 1977 1 : 385 401.
19. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) Examination. J Clin Psych 1987 48 : 314 318.
20. National Heart, Lung, and Blood Institute (NHLBI) Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults, 1998 [on-line]. Available at Accessed October 1, 2009
21. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York : John Wiley and Sons, Inc., 1989.
22. Shamliyan TA, Kane RL, Wyman J et al. Systematic review: Randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann Intern Med 2008 148 : 459 473.
23. DuBeau CE. Estrogen treatment for urinary incontinence: Never, now, or in the future? JAMA 2005 293 : 998 1001.
24. Marshall H, Beevers D. Alpha-adrenergic blockade and urinary incontinence. J Hypertens 1993 11 : 1152 1153.
25. JNC-7. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. NHLBI, 2003.
26. Rudolph JL, Salow MJ, Angelini MC et al. The Anticholinergic Risk Scale and anticholinergic adverse effects in older persons. Arch Intern Med 2008 168 : 508 513.
27. Kirschner-Hermanns R, Scherr PA, Branch LG et al. Accuracy of survey questions for geriatric urinary incontinence. J Urol 1998 159 : 1903 1908.